Concentration of IL-18 and PGE2 in synovial fluid in patients with osteoarthritis and its significance

Journal of Central South University (Medical Sciences)

Volumn 31, Issue 6, 2006, Pages 862-865

  Peng, Cheng Zhong ^a,b   Cao, Jian Min ^b   Xiao, Tao ^a   Peng, Cheng ^a   Yang, Hong Bo ^b   Cheng, Xiang ^b   Fang, Jian Zhen ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Cytokines; Interleukin 18; Osteoarthritis; Prostaglandin E2; Synovial fluid

Indexed keywords

INTERLEUKIN 18; PROSTAGLANDIN E2;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OSTEOARTHRITIS; PATHOGENESIS; SYNOVIAL FLUID;

ADULT; AGED; CASE-CONTROL STUDIES; DINOPROSTONE; FEMALE; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL FLUID;

EID: 33846276236     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Altman R, Asch E, Blochi D, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee [J]. Arthritis Rheum, 1986,29 (6):1039-1049.
2. Goldring Mary B, Berenbaum Francis M D. The regulation of chondrocyte function by proinflammatorymediators: prostaglandnis and nitric oxide [J]. Clini Orthop Relat Res, 2004,1 (427s):s37-46.
3. Okamura H, Tsintsi H, Komalsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells [J]. Nature, 1995,378(6552):88-91.
4. Ushio S, Nomba M, Okura T, et al. Cloning of the cDNA for humma IFN-r-inducing factor expression in escherichia coli and studies on the biologic activities of the protein [J]. J Immunol, 1996,156(11):4274-4279.
5. Rooney T, Murphy E, Benito M, et al. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis [J]. Annals Rheum, 2004, 63 (11):1393-1398.
6. Henrotin Y E, Zheng S X, Labasse A H, et al. Modulation of human chondrocyte metabolism by recombinant human interforn [J]. Osteoarthritis Cartilage, 2000,8(6):474-482.
7. Joosten L, Radstake T, Lubberts E, et al. Association of interleukin-18 expression with enhanced levels of both interleukin-1 [beta] and tumor necrosis factor [alpha] in knee synovial tissue of patients with rheumatoid arthritis [J]. Arthritis Rheum, 2003,48(2):339-347.
8. Ye X J, Tang Z, Kang A H, et al. The roles of interleukin-18 in collagan-induced arthritis in the BB rat [J]. Clin Exp Immunol, 2004,136(3):440-447.
9. Dai S M, Shan Z Z, Nishioka K, et al. Implication of interleukin -18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direca effect on chondrocytesmay not be pivotal [J]. Ann Rheum Dis, 2005,64(5):735-742.
10. Chinese source
11. 2 receptors in the pathogenesis of rheumatoid arthritis [J]. J Clin Invest, 2002,110(5):651-658.
12. 2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation [J]. J Immunol, 2002,25(s1):s61-64.
13. Amin A R, Abramson S B. The role of nitric oxide in articular cartilage breakdown in osteoarthritis [J]. Curr opin immunol, 1998,10(4):263-268.
14. Aizawa Y, Akita K, Taniai M, et al. Cloning and expression of interleukin-18 blinding protein [J]. Febs Lett, 1999,445 (2-3):338.
15. Lajeunesse D, Delalandre A, Martel-Pellelier J, et al. Hyaluronic acid reverse the abnormal synthetic activity of human osteoarthritic subchondral bone osteoblasts [J]. Bone, 2003,33 (4):703-710.